Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-serine in Early Stage Alzheimer's Disease
NCT03062449Phase 2Terminated
- Start
- Mar 2017
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of l-serine in Alzheimer's disease (AD). Started Mar 2017; status: terminated.
02
Drugs
l-serine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03062449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03062449.